Mestinon-SR 180 mg

MESTINON-SR 180 MG is an extended-release tablet containing pyridostigmine bromide, used to manage symptoms of myasthenia gravis. This medication helps improve muscle strength and function.

MESTINON-SR 180 MG is primarily used to treat myasthenia gravis, a condition that causes weakness in the voluntary muscles. Pyridostigmine bromide works by improving nerve-to-muscle communication, which can help alleviate muscle weakness and fatigue. This medication is often prescribed to manage symptoms and enhance muscle function in individuals with myasthenia gravis.

Common effects of MESTINON-SR 180 MG may include improved muscle strength and reduced fatigue. Some users might experience increased salivation, sweating, or gastrointestinal discomfort. These effects can vary depending on individual responses to the medication.

MESTINON-SR 180 MG should be handled with care, especially by individuals with certain medical conditions such as asthma, epilepsy, or stomach ulcers. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping this medication. Keep the tablets out of reach of children and store them as directed.

MESTINON-SR 180 MG may interact with other medications, including anticholinergics, which can reduce its effectiveness. It is also important to be cautious when combining this medication with alcohol or other substances that can affect the nervous system. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.